Trade Krystal Biotech, Inc. - KRYS CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 2.13
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.021512 %(-$0.43)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.02151%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.00071 %(-$0.01)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.00071%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 0.1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.021512 %
  (-$0.43)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.00071 %
  (-$0.01)

Key Stats

• Prev. Close: 350.07
• Open: 344.97
• 1-Year Change: 133.47%
• Day's Range: 344.97 - 349.97

Trade Krystal Biotech, Inc. - KRYS

What is Krystal Biotech, Inc. (KRYS)?

Krystal Biotech, Inc. is a biotechnology company focused on developing gene therapies for rare genetic skin diseases. The company utilizes proprietary gene editing and delivery technologies to create treatments aimed at addressing the underlying causes of dermatological conditions. Its research and development efforts concentrate on monogenic disorders, with an emphasis on innovative approaches to restore or replace defective genes. Krystal Biotech collaborates with scientific and medical communities to advance its therapeutic candidates through clinical development. The company operates within the biopharmaceutical sector, prioritizing translational research and regulatory compliance. Its mission centers on providing novel treatment options for patients with limited therapeutic alternatives in the field of dermatology.

Krystal Biotech, Inc. Stock Price Today: Live Overview

The price today is shaped by ongoing trades, with Krystal Biotech, Inc. currently trading at $349.22. Its price has fluctuated from $344.97 to $350.52, showing a daily percentage move of -0.0428%.

FAQ: Krystal Biotech, Inc. (KRYS)

What is the current price of KRYS stock?

Krystal Biotech, Inc. is currently priced at $349.22.

Does KRYS pay dividends?

Krystal Biotech, Inc. does not pay dividends.

Does KRYS have a formal corporate presence or regional headquarters in the UAE?

Krystal Biotech, Inc. operates in the UAE only via partners and distributors without an official regional presence.

What is KRYS best known for?

The company is most famous for its gene therapy product development.

What assets are typically shown together with KRYS?

Commonly shown alongside KRYS: AudioEye, Inc., Deutsche Telekom, Nexans